Diapocynin is primarily researched for its potential therapeutic applications due to its antioxidant and anti-inflammatory properties. It is being studied for its role in mitigating oxidative stress and inflammation in various diseases, such as neurodegenerative disorders like Parkinson's and Alzheimer's. Additionally, it shows promise in reducing complications associated with diabetes, particularly in protecting against diabetic nephropathy by alleviating oxidative damage in kidney cells. Research also explores its potential in cardiovascular health, where it may help reduce inflammation and oxidative stress in heart tissues. Its ability to modulate cellular pathways involved in inflammation makes it a candidate for further investigation in autoimmune and inflammatory conditions.